Welcome!

News Feed Item

Lombard Medical Technologies PLC: Pre-Close Trading and Strategic Update

LONDON, UK -- (Marketwired) -- 01/08/14 --


                   Lombard Medical Technologies PLC
                 ("Lombard Medical" or "the Company")

                Pre-Close Trading and Strategic Update

         Global AorfixTM growth; US rollout progressing well
  Intention to pursue a US IPO and NASDAQ listing of ordinary shares

London, UK and Irvine, CA, 8 January, 2014 - Lombard Medical
Technologies PLC (AIM: LMT), the specialist medical device company
focused on Endovascular Aortic Repair ("EVAR") of abdominal aortic
aneurysms ("AAAs"), announced today a pre-close trading update for the
financial year ended 31 December 2013 as well as a strategic update.
All figures are unaudited.

Trading Update

AorfixTM commercial revenue grew 25% to GBP3.9m with revenue from the
main EU markets growing 9%. Revenue from the Rest of World ("ROW")
markets grew 28% and the US contributed to fourth quarter Aorfix
commercial revenue growth of 38% following formal launch in November.
In Europe, the Company experienced strong demand and revenue growth in
Germany and Spain. Following consolidation of EVAR centers in the UK,
which negatively impacted UK revenue in the first half of 2013, second
half 2013 Aorfix revenue in the UK recovered and was flat compared to
the same period the previous year. Total Company revenue grew by 14% to
GBP4.5m, reflecting a decline in revenue of the recently divested OEM
business in Scotland which fell by 27% compared to last year. As
previously announced, this business was divested on 20 December 2013.

Aorfix was approved by the United States Food and Drug Administration
("US FDA") in February 2013 with a unique label indication for the
treatment of patients with angulations at the neck of the aneurysm up
to and including 90 degrees. The product was formally launched in the
US, the largest EVAR market, at the 40th Annual VEITH Symposium, in New
York in November. While Aorfix is still in the initial phase of the US
launch, the product rollout is progressing well, with the number of US
physicians trained to use the device standing at 244 at the year end.
As previously disclosed, the Company's 20-person sales team is
targeting around 300 high volume EVAR centers that perform more than
half of the EVAR procedures in the US.

In Japan, the Company now anticipates regulatory approval for Aorfix
during 2014. Our exclusive Japanese marketing partner, Medico's
Hirata, remains in dialogue with the Pharmaceuticals and Medical
Devices Agency (PMDA) to achieve this. Medico's Hirata is a leading
supplier of medical device products in Japan, with the sales
infrastructure to realize the potential of Aorfix in this growing
market, which in 2013 was estimated to account for approximately $140m
or 10% of the global EVAR market.

As previously announced, the Company is expanding its manufacturing
facility in Didcot, Oxfordshire, to support increasing global demand
for Aorfix. The expansion, which involves the construction of a new
cleanroom and materials handling space, will add around 10,000 sq. ft.
to the existing facility. The expansion project is expected to be
completed by the end of the first quarter of 2014.

The global AAA market for EVAR devices is estimated to be approximately
$1.4bn. The US market is estimated to be worth around half of the
global market and is expected to grow at a compound annual growth rate
in excess of 7% over the next 5 years, driven largely by the growth of
the ageing population and patient screening programs. In addition,
introduction of new technologies such as Aorfix, which allow more
patients to received endovascular treatment of AAA disease, could
potentially further expand the market.

The Company closed 2013 with cash of GBP24.8m and debt of GBP1.5m on its
balance sheet.

NASDAQ IPO

As announced today in a separate press release, the Company intends to
submit a registration statement to the US Securities and Exchange
Commission ("SEC") relating to a proposed US initial public offering of
ordinary shares and a listing on NASDAQ ("NASDAQ IPO").

To facilitate the NASDAQ IPO, a new Cayman Islands holding company will
be created and existing shares in Lombard Medical will be exchanged for
new shares in that holding company ("Share Exchange")

Commencement of the initial public offering is conditional upon
completion of the SEC review process with respect to the registration
statement and is subject to market conditions and other
considerations. In connection with the NASDAQ IPO, Lombard Medical
will also delist its ordinary shares from AIM, a market of the London
Stock Exchange.

In the Share Exchange, existing shareholders will receive shares in the
new Cayman Islands holding company in exchange for the shares they hold
in Lombard Medical. These new shares will not be admitted to trading on
AIM. Shareholders will need to consider their ability to hold and trade
NASDAQ listed shares following the Share Exchange and the AIM
delisting. Full details of the proposals will be set out in a circular
to shareholders in due course.

Lombard Medical intends to use proceeds from the NASDAQ IPO to
accelerate its commercialization strategy for Aorfix in the US with a
particular focus on continuing to expand its direct sales force to
accelerate penetration of the US AAA market. The Company will also
continue to invest in developing new products to treat complex vascular
disease, including a stent graft to treat aneurysms in the thoracic
aorta.

This press release does not constitute an offer of any securities for
sale.

                               -Ends-


For further information:

Lombard Medical Technologies PLC              Tel: +44 (0)1235 750 800
Simon Hubbert, Chief Executive Officer
Ian Ardill, Chief Financial Officer

Canaccord Genuity Limited                     Tel: +44 (0)20 7523 8000
Lucy Tilley / Tim Redfern /
Henry Fitzgerald O'Connor / Dr Julian Feneley

FTI Consulting (UK)                           Tel: +44 (0)20 7831 3113
Simon Conway / Stephanie Cuthbert /
Victoria Foster Mitchell

Allen & Caron (US)                            Tel: +1 (949) 474 4300
Matt Clawson


About Abdominal Aortic Aneurysms

AAAs are a balloon-like enlargement of the aorta which, if left
untreated, may rupture and cause death. Approximately 4.5 million
people are living with AAAs in the developed world and each year over
500,000 new cases are diagnosed. In the US, aortic aneurysm disease is
among the leading causes of death and it is estimated that 1.7 million
people over the age of 55 have an abdominal aortic aneurysm.

About Lombard Medical

Lombard Medical Technologies PLC (AIM: LMT) is a medical device company
focused on device solutions for the $1.4 billion per annum abdominal
aortic aneurysm ("AAA") repair market. The Company's lead product,
Aorfix, is an endovascular stent graft which has been specifically
designed to solve the problems that exist in treating complex tortuous
anatomy, which is often present in advanced AAA disease. Aorfix is the
only stent graft approved for AAA neck angulations of up to 90 degrees
and is currently being commercialized worldwide. Aorfix is the first
AAA stent graft not of US origin to gain US FDA approval. The Company
is headquartered in Oxfordshire, England with US operations in Irvine,
CA.

Further background on the Company can be found at
www.lombardmedical.com.

FORWARD-LOOKING STATEMENTS

This announcement may contain forward-looking statements that reflect
the Company's current expectations regarding future events, including
the commercialization and regulatory clearance of the Company's
products, the Group's liquidity and results of operations, as well as
the Group's future capital raising activities. Forward-looking
statements involve risks and uncertainties. Actual events could differ
materially from those projected herein and depend on a number of
factors, including the success of the Company's research and
development and commercialization strategies, the uncertainties related
to the regulatory process and the acceptance of the Company's products
by hospitals and other medical professionals.



                    This information is provided by RNS
          The company news service from the London Stock Exchange

END

Contacts:
RNS
Customer
Services
0044-207797-4400
Email Contact
http://www.rns.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
The Internet of Things can drive efficiency for airlines and airports. In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect with GE, and Sudip Majumder, senior director of development at Oracle, discussed the technical details of the connected airline baggage and related social media solutions. These IoT applications will enhance travelers' journey experience and drive efficiency for the airlines and the airports.
SYS-CON Events announced today that WineSOFT will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Based in Seoul and Irvine, WineSOFT is an innovative software house focusing on internet infrastructure solutions. The venture started as a bootstrap start-up in 2010 by focusing on making the internet faster and more powerful. WineSOFT’s knowledge is based on the expertise of TCP/IP, VPN, SSL, peer-to-peer, mob...
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain.
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, whic...
Have you ever noticed how some IT people seem to lead successful, rewarding, and satisfying lives and careers, while others struggle? IT author and speaker Don Crawley uncovered the five principles that successful IT people use to build satisfying lives and careers and he shares them in this fast-paced, thought-provoking webinar. You'll learn the importance of striking a balance with technical skills and people skills, challenge your pre-existing ideas about IT customer service, and gain new in...
WebRTC sits at the intersection between VoIP and the Web. As such, it poses some interesting challenges for those developing services on top of it, but also for those who need to test and monitor these services. In his session at WebRTC Summit, Tsahi Levent-Levi, co-founder of testRTC, reviewed the various challenges posed by WebRTC when it comes to testing and monitoring and on ways to overcome them.
SYS-CON Events announced today that Catchpoint Systems, Inc., a provider of innovative web and infrastructure monitoring solutions, has been named “Silver Sponsor” of SYS-CON's DevOps Summit at 18th Cloud Expo New York, which will take place June 7-9, 2016, at the Javits Center in New York City, NY. Catchpoint is a leading Digital Performance Analytics company that provides unparalleled insight into customer-critical services to help consistently deliver an amazing customer experience. Designed ...
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
Tintri VM-aware storage is the simplest for virtualized applications and cloud. Organizations including GE, Toyota, United Healthcare, NASA and 6 of the Fortune 15 have said "No to LUNs." With Tintri they manage only virtual machines, in a fraction of the footprint and at far lower cost than conventional storage. Tintri offers the choice of all-flash or hybrid-flash platform, converged or stand-alone structure and any hypervisor. Rather than obsess with storage, leaders focus on the business app...
The financial services market is one of the most data-driven industries in the world, yet it’s bogged down by legacy CPU technologies that simply can’t keep up with the task of querying and visualizing billions of records. In his session at 20th Cloud Expo, Jared Parker, Director of Financial Services at Kinetica, will discuss how the advent of advanced in-database analytics on the GPU makes it possible to run sophisticated data science workloads on the same database that is housing the rich inf...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
Ayehu provides IT Process Automation & Orchestration solutions for IT and Security professionals to identify and resolve critical incidents and enable rapid containment, eradication, and recovery from cyber security breaches. Ayehu provides customers greater control over IT infrastructure through automation. Ayehu solutions have been deployed by major enterprises worldwide, and currently, support thousands of IT processes across the globe. The company has offices in New York, California, and Isr...
LogMeIn has completed its previously disclosed merger with Citrix Systems, Inc.’s GetGo, Inc. subsidiary, a wholly owned subsidiary consisting of Citrix’s GoTo family of service offerings. The merger officially closed after market hours on January 31, 2017. Effected through a Reverse Morris Trust transaction, the merger brings together two of the preeminent players in cloud connectivity to instantly create one of the world’s top 10 public SaaS companies, and a market leader with the scale, resou...
In his session at @ThingsExpo, Steve Wilkes, CTO and founder of Striim, will delve into four enterprise-scale, business-critical case studies where streaming analytics serves as the key to enabling real-time data integration and right-time insights in hybrid cloud, IoT, and fog computing environments. As part of this discussion, he will also present a demo based on its partnership with Fujitsu, highlighting their technologies in a healthcare IoT use-case. The demo showcases the tracking of patie...
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settle...